
Half a Century Later, Parkinson’s Miracle Pill Still Out of Reach for Many
Despite being a 50-year-old, inexpensive, and effective treatment for Parkinson's disease, levodopa remains inaccessible to many worldwide due to systemic political, logistical, and regulatory failures. The authors call for a coordinated global response to make levodopa universally available, affordable, and safe, similar to the successful international efforts against HIV/AIDS, emphasizing that access to this life-changing medication is a matter of human rights and public health urgency.



